Full Professor(heuristic)

Colorectal Cancer Treatments and Studies · Oncology

h-index53
i10-index126
Publications536
Citations30,857

Grants

23 total · 12 active

NIH #5R01CA296410-02

Optimization of an active mutant KRAS peptide vaccine in colorectal cancer

Active
Amount
$591K
Period
2025-01-10 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #1R01CA296410-01

Optimization of an active mutant KRAS peptide vaccine in colorectal cancer

Active
Amount
$590K
Period
2025-01-10 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5T32CA009071-44

Molecular Targets for Cancer Detection and Treatment

Active
Amount
$552K
Period
1979-09-15 → 2027-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

23 total · 12 active

NIH #5R01CA296410-02

Optimization of an active mutant KRAS peptide vaccine in colorectal cancer

Active
Amount
$591K
Period
2025-01-10 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #1R01CA296410-01

Optimization of an active mutant KRAS peptide vaccine in colorectal cancer

Active
Amount
$590K
Period
2025-01-10 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5T32CA009071-44

Molecular Targets for Cancer Detection and Treatment

Active
Amount
$552K
Period
1979-09-15 → 2027-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5T32CA009071-43

Molecular Targets for Cancer Detection and Treatment

Active
Amount
$502K
Period
1979-09-15 → 2027-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5T32CA009071-42

Molecular Targets for Cancer Detection and Treatment

Active
Amount
$445K
Period
1979-09-15 → 2027-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #2T32CA009071-41A1

Molecular Targets for Cancer Detection and Treatment

Active
Amount
$436K
Period
1979-09-15 → 2027-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P30CA006973-63

Cancer Genetics and Epigenetics

Active
Amount
$302K
Period
1997-05-07 → 2027-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P01CA247886-05

Mechanisms of immunomodulation with epigenetic therapy

Active
Amount
$313K
Period
2021-06-01 → 2027-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P30CA006973-62

Cancer Genetics and Epigenetics

Active
Amount
$299K
Period
1997-05-07 → 2027-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P30CA006973-61

Cancer Genetics and Epigenetics

Active
Amount
$54K
Period
1997-05-07 → 2027-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P30CA006973-60

Cancer Genetics and Epigenetics

Active
Amount
$54K
Period
1997-05-07 → 2027-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #2P30CA006973-59

Cancer Genetics and Epigenetics

Active
Amount
$54K
Period
1997-05-07 → 2027-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P01CA247886-04

Mechanisms of immunomodulation with epigenetic therapy

Amount
$298K
Period
2021-06-01 → 2026-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P01CA247886-03

Mechanisms of immunomodulation with epigenetic therapy

Amount
$307K
Period
2021-06-01 → 2026-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P01CA247886-02

Mechanisms of immunomodulation with epigenetic therapy

Amount
$307K
Period
2021-06-01 → 2026-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #1P01CA247886-01A1

Mechanisms of immunomodulation with epigenetic therapy

Amount
$313K
Period
2021-06-01 → 2026-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5R01CA228414-04

Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma

Amount
$412K
Period
2018-07-03 → 2023-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5T32CA009071-40

Molecular Targets for Cancer Detection and Treatment

Amount
$606K
Period
1979-09-15 → 2022-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5R01CA228414-03

Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma

Amount
$424K
Period
2018-07-03 → 2022-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5R01CA228414-02

Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma

Amount
$391K
Period
2018-07-03 → 2022-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #1R01CA228414-01

Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma

Amount
$391K
Period
2018-07-03 → 2022-06-30
PIs
2
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5R21CA172997-02

Targeting RAS signaling with CDK and AKT inhibition in pancreatic cancer

Amount
$171K
Period
2013-07-01 → 2016-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #1R21CA172997-01A1

Targeting RAS signaling with CDK and AKT inhibition in pancreatic cancer

Amount
$211K
Period
2013-07-01 → 2015-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at JOHNS HOPKINS UNIVERSITY

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 123
Open author page on OpenAlex →